Insight Molecular Diagnostics Inc. (IMDX)
Data as of , from SEC Form 4 filings.
No open-market insider trades (90d)Watch IMDX
See up to 3 months of IMDX. The 7-day demo opens the 1M and 3M ranges and puts IMDX on your watchlist.
Start 7-day demoLatest IMDX insider trades
About Insight Molecular Diagnostics Inc. (IMDX)
Insight Molecular Diagnostics Inc. is an SEC registrant, filing under CIK 0001642380, classified as in vitro and in vivo diagnostic substances. We track it alongside the rest of the Health Care sector.
IMDX Form 4 activity by transaction type, last 90 days
No Form 4 activity for IMDX in the last 90 days.
IMDX insider transactions (Form 4)
4826 Form 4 filings on record, the earliest from Oct 4, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Lou Silverman - Director | Tax withholding / forfeiture | Common Stock, no par value | 7,700 | $5.69 | $44K | |
| Andrew J. Last - Director | Tax withholding / forfeiture | Common Stock, no par value | 7,700 | $5.69 | $44K | |
| Andrew Arno - Director | Tax withholding / forfeiture | Common Stock, no par value | 12,100 | $5.69 | $69K | |
| Lou Silverman - Director | Grant or award | Common Stock, no par value | 26,943 | $0.00 | - | |
| Andrew J. Last - Director | Grant or award | Common Stock, no par value | 26,943 | $0.00 | - | |
| Andrew Arno - Director | Grant or award | Common Stock, no par value | 32,331 | $0.00 | - | |
| BROADWOOD PARTNERS, L.P. - 10% Owner | Open-market purchase | Common Stock, no par value | 0 | $0.00 | - | |
| BROADWOOD PARTNERS, L.P. - 10% Owner | Open-market purchase | Common Stock, no par value | 280,381 | $3.50 footnote F3 | $982K | |
| BROADWOOD PARTNERS, L.P. - 10% Owner | Open-market purchase | Common Stock, no par value | 38,880 | $3.53 footnote F4 | $137K | |
| BROADWOOD PARTNERS, L.P. - 10% Owner | Open-market purchase | Common Stock, no par value | 0 | $0.00 | - | |
| BROADWOOD PARTNERS, L.P. - 10% Owner | Open-market purchase | Common Stock, no par value | 250,923 | $3.64 footnote F5 | $913K | |
| BROADWOOD PARTNERS, L.P. - 10% Owner | Open-market purchase | Common Stock, no par value | 0 | $0.00 | - | |
| ||||||
| BROADWOOD PARTNERS, L.P. - 10% Owner | Open-market purchase | Common Stock, no par value | 102,057 | $3.45 footnote F3 | $352K | |
| BROADWOOD PARTNERS, L.P. - 10% Owner | Open-market purchase | Common Stock, no par value | 0 | $0.00 | - | |
| BROADWOOD PARTNERS, L.P. - 10% Owner | Open-market purchase | Common Stock, no par value | 40,114 | $3.57 footnote F4 | $143K | |
| BROADWOOD PARTNERS, L.P. - 10% Owner | Open-market purchase | Common Stock, no par value | 0 | $0.00 | - | |
| BROADWOOD PARTNERS, L.P. - 10% Owner | Open-market purchase | Common Stock, no par value | 40,690 | $3.88 footnote F5 | $158K | |
| BROADWOOD PARTNERS, L.P. - 10% Owner | Open-market purchase | Common Stock, no par value | 0 | $0.00 | - | |
| ||||||
| Andrea S. James - Officer | Option exercise | Common Stock | 28,302 | - footnote F1 | - | |
| Andrea S. James - Officer | Tax withholding / forfeiture | Common Stock | 11,298 footnote F2 | $4.11 | $46K | |
| Andrea S. James - Officer | Option exercise | Restricted Stock Units | 28,302 | $0.00 | - | |
| ||||||
| James Yang Liu - Officer | Option exercise | Common Stock | 6,289 | - footnote F1 | - | |
| James Yang Liu - Officer | Tax withholding / forfeiture | Common Stock | 2,578 footnote F2 | $4.11 | $11K | |
| James Yang Liu - Officer | Option exercise | Restricted Stock Units | 6,289 | $0.00 | - | |
| ||||||
| Josh Riggs - Officer | Option exercise | Common Stock | 47,170 | - footnote F1 | - | |
| Josh Riggs - Officer | Tax withholding / forfeiture | Common Stock | 12,310 footnote F2 | $4.11 | $51K | |
| Josh Riggs - Officer | Option exercise | Restricted Stock Units | 47,170 | $0.00 | - | |
| ||||||
| BROADWOOD PARTNERS, L.P. - 10% Owner | Open-market purchase | Common Stock, no par value | 521,739 | $5.75 footnote F3 | $3.00M | |
| BROADWOOD PARTNERS, L.P. - 10% Owner | Open-market purchase | Common Stock, no par value | 0 | $0.00 | - | |
| ||||||
| Andrea S. James - Officer | Option exercise | Common Stock | 50,000 | $0.00 | - | |
| Andrea S. James - Officer | Tax withholding / forfeiture | Common Stock | 12,175 | $6.01 | $73K | |
| Andrea S. James - Officer | Option exercise | Restricted Stock Units | 50,000 | $0.00 | - | |
| Andrea S. James - Officer | Derivative | Restricted Stock Units | 50,000 footnote F1 | $0.00 footnote F1 | - | |
| Andrea S. James - Officer | Option exercise | Common Stock | 50,000 footnote F1 | $0.00 footnote F1 | - | |
| ||||||
| James Yang Liu - Officer | Grant or award | Option to Purchase Common Stock | 18,000 | $0.00 | - | |
| Andrea S. James - Officer | Grant or award | Option to Purchase Common Stock | 235,000 | $0.00 | - | |
| Josh Riggs - Officer | Grant or award | Option to Purchase Common Stock | 400,000 | $0.00 | - | |
| Andrew J. Last - Director | Grant or award | Common Stock, no par value | 35,000 | $0.00 | - | |
| Andrew Arno - Director | Grant or award | Common Stock, no par value | 55,000 | $0.00 | - | |
| Lou Silverman - Director | Grant or award | Common Stock, no par value | 35,000 | $0.00 | - | |
| Patrick W. Smith - 10% Owner | Open-market purchase | Common Stock, no par value | 90,219 | $2.13 | $192K | |
| Andrew Arno - Director | Open-market purchase | Common Stock, no par value | 12,500 | $2.11 | $26K | |
| Andrea S. James - Officer | Open-market purchase | Common Stock, no par value | 20,000 | $2.29 | $46K | |
| Andrea S. James - Officer | Grant or award | Options to Purchase Common Stock | 200,000 | $0.00 | - | |
| Andrea S. James - Officer | Grant or award | Restricted Stock Units | 100,000 | $0.00 | - | |
| Andrea S. James - Officer | Open-market purchase | Common Stock, no par value | 33,670 | $2.97 | $100K | |
| BROADWOOD PARTNERS, L.P. - 10% Owner | Open-market purchase | Common Stock, no par value | 1,315,339 | $2.95 | $3.88M | |
| BROADWOOD PARTNERS, L.P. - 10% Owner | Open-market purchase | Common Stock, no par value | 0 | $0.00 | - | |
Item 1.01, 9.01
Item 2.02, 7.01, 8.01, 9.01
Item 5.02, 5.07, 9.01
Item 2.02, 9.01
IMDX insider trading FAQ
What is the latest insider trade for IMDX?
Insight Molecular Diagnostics Inc. (IMDX) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-07-07. The full record for IMDX runs to 26 Form 4 filings, the earliest from 2024-10-04. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying IMDX stock?
No insider purchases of IMDX were filed in the last 90 days. 20 purchases are on record for this company.
How many insiders are selling IMDX stock?
No insider sales of IMDX were filed in the last 90 days.
Where can I see IMDX SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects IMDX Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Lou Silverman view on EDGAR
- - Andrew J. Last view on EDGAR
- - Andrew Arno view on EDGAR
- - Lou Silverman view on EDGAR
- - Andrew J. Last view on EDGAR
- - Andrew Arno view on EDGAR
- - BROADWOOD PARTNERS, L.P. view on EDGAR
- - BROADWOOD PARTNERS, L.P. view on EDGAR
- - Andrea S. James view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where IMDX's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow IMDX with a 7-day demo
- IMDX on your watchlist
- Every IMDX Form 4 filing on record
- Up to 3 months of IMDX price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
